MARKET

GSK

GSK

GSK PLC
NYSE
60.23
+1.06
+1.79%
After Hours: 60.02 -0.21 -0.35% 19:51 02/06 EST
OPEN
59.29
PREV CLOSE
59.17
HIGH
60.37
LOW
59.25
VOLUME
8.15M
TURNOVER
--
52 WEEK HIGH
60.37
52 WEEK LOW
31.37
MARKET CAP
122.73B
P/E (TTM)
16.12
1D
5D
1M
3M
1Y
5Y
1D
Big Pharma's Earnings Week: Strong Performance, Obesity Wars, LOE Management And More
Seeking Alpha · 1d ago
GSK shares uptick for seven consecutive sessions
Seeking Alpha · 1d ago
GSK wins EU nod to expand Nucala for COPD
Seeking Alpha · 1d ago
Trump Trade: Argentina says U.S. to cut hundreds of tariffs
TipRanks · 1d ago
GSK announces European Commission approved Nucala
TipRanks · 2d ago
Kepler Capital Reaffirms Their Hold Rating on GlaxoSmithKline (GSK)
TipRanks · 2d ago
GSK Wins EU Approval for Nucala as Add-On COPD Treatment
Reuters · 2d ago
EU-Kommission lässt GSKs Nucala zur Behandlung von COPD zu
Reuters · 2d ago
More
About GSK
GSK plc is a biopharma company. The Company’s segments include Commercial Operations and Research and Development. Its portfolio and pipeline are focused on developing medicines and vaccines in four core therapeutic areas, which are the areas of human health it focuses on to prevent and treat disease: respiratory, immunology and inflammation; oncology; human immunodeficiency virus (HIV), and infectious diseases. Its specialty medicines prevent and treat diseases, from HIV to respiratory diseases, immune-mediated conditions like lupus, and cancer. Its vaccine portfolio includes over 20 vaccines to protect people from diseases and infections throughout their lives. General medicines include inhaled medicines for asthma and COPD to antibiotics. It develops and commercializes preclinical antibody-drug conjugate for Metastatic castration-resistant prostate cancer. Its portfolio also includes Efimosfermin, a fibroblast growth factor 21 (FGF21) analog therapeutic in clinical development.

Webull offers GSK plc (ADR) stock information, including NYSE: GSK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GSK stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GSK stock methods without spending real money on the virtual paper trading platform.